Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics - Says it has completed the conditional sale agreement for Omega's diagnostic test kit manufacturing business and facility in Alva, Scotland. Agreement is with Accubio Ltd, a wholly-owned subsidiary of Zhejiang Orient Gene Biotech Co Ltd for a cash consideration of £1 million.
Chief Executive Officer Jag Grewal comments: ‘We are extremely pleased to confirm the sale of the historical Alva site today, ensuring job security for all employees transferring to Accubio. This is the first step in our planned strategy to reshape and restructure the business.’
Current stock price: 5.35 pence, up 21% on Monday
12-month change: down 94%
Copyright 2022 Alliance News Limited. All Rights Reserved.